Detalhe da pesquisa
1.
Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient settings.
Curr Probl Cardiol
; 49(2): 102239, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38056515
2.
Dostarlimab or pembrolizumab plus chemotherapy in previously untreated metastatic non-squamous non-small cell lung cancer: the randomized PERLA phase II trial.
Nat Commun
; 14(1): 7301, 2023 11 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951954
3.
Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: a novel metabolomics approach.
Mol Oncol
; 16(14): 2658-2671, 2022 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-35338693
4.
Identification of ALK-positive patients with advanced NSCLC and real-world clinical experience with crizotinib in Spain (IDEALK study).
Lung Cancer
; 173: 83-93, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36162227
5.
Human Plasma Metabolomics for Biomarker Discovery: Targeting the Molecular Subtypes in Breast Cancer.
Cancers (Basel)
; 13(1)2021 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33466323
6.
Early use of tocilizumab in patients with severe pneumonia secondary to severe acute respiratory syndrome coronavirus 2 infection and poor prognostic criteria: Impact on mortality rate and intensive care unit admission.
Medicine (Baltimore)
; 100(29): e26533, 2021 Jul 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-34398008
7.
"High Tumor Burden" in Metastatic Non-Small Cell Lung Cancer: Defining the Concept.
Cancer Manag Res
; 13: 4665-4670, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34163241
8.
Lung cancer symptoms at diagnosis: results of a nationwide registry study.
ESMO Open
; 5(6): e001021, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-33214227
9.
A Randomized Open-Label Phase III Trial Evaluating the Addition of Denosumab to Standard First-Line Treatment in Advanced NSCLC: The European Thoracic Oncology Platform (ETOP) and European Organisation for Research and Treatment of Cancer (EORTC) SPLENDOUR Trial.
J Thorac Oncol
; 15(10): 1647-1656, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32565388
10.
Patterns of Progression and Feasibility of Re-biopsy After First-line Erlotinib for Advanced EGFR Mutation-positive Non-small-cell Lung Cancer.
Anticancer Res
; 39(3): 1317-1328, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30842164
11.
Lung cancer in Spain: information from the Thoracic Tumors Registry (TTR study).
Transl Lung Cancer Res
; 8(4): 461-475, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31555519
12.
Metabolomics signature as a survival predictor in patients with resectable colorectal liver metastasis.
Clin Transl Med
; 14(1): e1541, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38239072
13.
A multicentre observational study of the effectiveness, safety and economic impact of nivolumab on non-small-cell lung cancer in real clinical practice.
Int J Clin Pharm
; 41(1): 272-279, 2019 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-30578473
14.
Tumour molecular subtyping according to hormone receptors and HER2 status defines different pathological complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer.
Clin Transl Oncol
; 10(10): 646-53, 2008 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-18940745
15.
SARS-CoV-2 Infection in Patients with Lung Cancer: Current Clinical Context. / Situación clínica de infección por SARS-CoV-2 en pacientes con carcinoma broncogénico: contexto actual.
Arch Bronconeumol (Engl Ed)
; 56(10): 684, 2020 Oct.
Artigo
em Inglês, Espanhol
| MEDLINE | ID: mdl-32336565
16.
Situación clínica de infección por SARS-Cov-2 en pacientes con carcinoma broncogénico: Contexto Actual / Sars-Cov-2 Infection in patients with lung cancer: current clinical context
Arch. bronconeumol. (Ed. impr.)
; 56(10): 684-685, oct. 2020.
Artigo
em Espanhol
| IBECS (Espanha) | ID: ibc-186845
17.
Safety and efficacy of neo-adjuvant sequential dose-dense chemotherapy doublets combined with trastuzumab in patients with HER-2-positive early stage breast cancer.
Breast J
; 14(5): 506-7, 2008.
Artigo
em Inglês
| MEDLINE | ID: mdl-18705667